Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18062364 | 0.94 | KDM4E (0.41) | KDM4EATML3MBTL1PGR | |
| SCHEMBL17071000 | 0.94 | KDM4E (0.41) | KDM4EATML3MBTL1PGR | |
| SCHEMBL16076341 | 0.94 | KDM4E (0.47) | KDM4EATML3MBTL1HDAC4MAPK8 | |
| SCHEMBL16940903 | 0.93 | KDM4E (0.46) | KDM4EATML3MBTL1HDAC4MAPK8 | |
| SCHEMBL16076353 | 0.93 | KDM4E (0.46) | KDM4EATML3MBTL1HDAC4MAPK8 | |
| SCHEMBL18351605 | 0.92 | KDM4E (0.51) | KDM4EATML3MBTL1HDAC4MAPK8 | |
| SCHEMBL18351613 | 0.90 | KDM4E (0.51) | KDM4EATML3MBTL1HDAC4MAPK8 | |
| SCHEMBL16076436 | 0.90 | KDM4E (0.40) | KDM4EATML3MBTL1 | |
| SCHEMBL14822438 | 0.90 | KDM4E (0.55) | KDM4EATML3MBTL1HDAC4MAPK8 | |
| SCHEMBL18062348 | 0.90 | KDM4E (0.41) | KDM4EATML3MBTL1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3042944-B1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE | LUMINESCENCE TECH CORP (TW) | 2017-05-10 | — | — | EP | disclosed |
| EP-3042944-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE | Luminescence Technology Corp. (TW) | 2016-07-13 | — | — | EP | disclosed |
| US-9190619-B2 | Compound for organic electroluminescence device | LUMINESCENCE TECHNOLOGY CORP (TW) | 2015-11-17 | — | — | US | disclosed |
| US-9190619-B2 | Compound for organic electroluminescence device | LUMINESCENCE TECHNOLOGY CORP (TW) | 2015-11-17 | — | — | US | disclosed |
| US-20150214492-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | LUMINESCENCE TECHNOLOGY CORP (TW) | 2015-07-30 | — | — | US | disclosed |
| US-20150214492-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | LUMINESCENCE TECHNOLOGY CORP (TW) | 2015-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150214492-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLCO4C1, LEF1, SLCO2B1 | KDM4E 2458/4885ATM 3958/4885L3MBTL1 1111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.